Posted by Admin | 9:29 AM

Pro Publica has updated their database of payments by pharmaceutical payments to physicians and organizations.  It now has data from 15 comp...

Labels: conflicts of interest, key opinion leaders, logical fallacies, marketing, pharmaceuticals, stealth marketing

Posted by Admin | 9:11 AM

This may be a first.  A Wall Street Journal story announced that the "key opinion leader" who played a pivotal role in the promot...

Labels: conflicts of interest, Endo Health Solutions, evidence-based medicine, guidelines, JCAHO, key opinion leaders, narcotics, Purdue Pharma, regulatory capture, stealth marketing

Posted by Admin | 5:00 AM

The latest  and biggest legal settlement involving health care to hit the news, that of GlaxoSmithKline (GSK) and the US government, has man...

Labels: CME, crime, deception, GlaxoSmithKline, key opinion leaders, kickbacks, legal settlements, manipulating clinical research, Martin Keller, Paxil, stealth marketing, suppression of medical research

Posted by Admin | 9:41 AM

The British Medical Journal just published an anonymous article by a pharmaceutical company insider that explained once again how pharmaceut...

Labels: conflicts of interest, deception, global health, health care corruption, key opinion leaders, manipulating clinical research, stealth marketing, suppression of medical research

Posted by Admin | 4:52 AM

I have not been writing much the past few weeks due to other concerns, and will probably not write much this summer. However, I have been co...

Labels: Healthcare IT experiment, In the Pipeline, medical ethics, sockpuppet, stealth marketing, Vioxx